Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | March 31, 2020

EDTX Monthly Wrap-Up March 2020

Article | March 31, 2020

Client Advocacy Tips For Remote Hearings During COVID-19

Blog | March 27, 2020

Led Zeppelin Paves the Way for Katy Perry

Webinar | March 26, 2020

Trade Secrets: Protection & Defense

Blog | March 26, 2020

Federal Circuit Denies Rehearing in Arthrex v. Smith & Nephew

Media Coverage | March 24, 2020

Ban On IPR Time-Bar Tricks Will Spur New Strategies

Law360

Michael T. Hawkins

Blog | March 23, 2020

Legal Alert: Federal Circuit Says PTAB Joinder Rules Contrary to Law

Blog | March 20, 2020

Insulin and Other Biological Products Previously Regulated as "Drugs" Transition to Biologics Regulation on March 23, 2020

Blog | March 19, 2020

Autonomous Vehicles Q&A

News | March 18, 2020

Fish & Richardson Named Top IP Litigation Firm of the Year in California by Benchmark Litigation

News | March 18, 2020

Fish & Richardson Receives Top "Band 1" 2020 Rankings for Patent and ITC Practices from Chambers Global

News | March 16, 2020

Three Fish & Richardson Attorneys Named to the San Diego Top Lawyers 2020 List